DE60135638D1 - Verbindung mit chelationsaffinität und selektivitäe - Google Patents

Verbindung mit chelationsaffinität und selektivitäe

Info

Publication number
DE60135638D1
DE60135638D1 DE60135638T DE60135638T DE60135638D1 DE 60135638 D1 DE60135638 D1 DE 60135638D1 DE 60135638 T DE60135638 T DE 60135638T DE 60135638 T DE60135638 T DE 60135638T DE 60135638 D1 DE60135638 D1 DE 60135638D1
Authority
DE
Germany
Prior art keywords
inhibition
decrease
series elements
transition series
selectivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60135638T
Other languages
German (de)
English (en)
Inventor
Harry S Winchell
Joseph Y Klein
Elliot D Simhon
Rosa L Cyjon
Ofer Klein
Haim Zaklad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chelator LLC
Original Assignee
Chelator LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chelator LLC filed Critical Chelator LLC
Application granted granted Critical
Publication of DE60135638D1 publication Critical patent/DE60135638D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE60135638T 2000-02-22 2001-02-14 Verbindung mit chelationsaffinität und selektivitäe Expired - Lifetime DE60135638D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/510,134 US6264966B1 (en) 2000-02-22 2000-02-22 Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
PCT/US2001/004977 WO2001062262A1 (en) 2000-02-22 2001-02-14 Compounds with chelation affinity and selectivity for first transition series elements and their use

Publications (1)

Publication Number Publication Date
DE60135638D1 true DE60135638D1 (de) 2008-10-16

Family

ID=24029507

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60135638T Expired - Lifetime DE60135638D1 (de) 2000-02-22 2001-02-14 Verbindung mit chelationsaffinität und selektivitäe
DE0001261349T Pending DE01909263T1 (de) 2000-02-22 2001-02-14 Verbindung mit Chelationsaffinität und Selektivität für Elemente der ersten Übergangselement-Reihe

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0001261349T Pending DE01909263T1 (de) 2000-02-22 2001-02-14 Verbindung mit Chelationsaffinität und Selektivität für Elemente der ersten Übergangselement-Reihe

Country Status (10)

Country Link
US (2) US6264966B1 (https=)
EP (2) EP1261349B1 (https=)
JP (1) JP2003523394A (https=)
AT (1) ATE406902T1 (https=)
AU (1) AU2001237038A1 (https=)
CA (1) CA2399299C (https=)
DE (2) DE60135638D1 (https=)
ES (1) ES2239924T1 (https=)
IL (2) IL151031A0 (https=)
WO (1) WO2001062262A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
OA12514A (en) 1999-12-24 2006-05-29 Aventis Pharma Ltd Azaindoles.
US6264966B1 (en) * 2000-02-22 2001-07-24 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
US6881732B2 (en) * 2002-06-13 2005-04-19 Chelator Llc Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements
BRPI0410505A (pt) * 2003-05-07 2006-06-20 Dmi Biosciences Inc métodos e produtos para cuidados orais
US20050112066A1 (en) * 2003-11-26 2005-05-26 Concat Lp, A California Limited Partnership Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity
US7659233B2 (en) * 2004-10-25 2010-02-09 Conopco, Inc. Personal care compositions with silicones and dihydroxypropyl trialkyl ammonium salts
US8476251B2 (en) 2010-07-29 2013-07-02 Conopco, Inc. Skin care compositions comprising substituted diamines
US8293218B2 (en) 2010-07-29 2012-10-23 Conopco, Inc. Skin care compositions comprising substituted monoamines
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN103086922A (zh) * 2013-02-07 2013-05-08 东华大学 一种n-烷氧基-4-戊烯酰胺类化合物及其制备方法
KR101709124B1 (ko) * 2015-08-19 2017-02-22 기초과학연구원 신규한 키랄 금속 착물 및 분광법에 의해 전하를 띤 화합물의 키랄성을 분석하기 위한 이의 용도
KR20180095871A (ko) 2015-12-16 2018-08-28 프리오스타 피티와이 엘티디 덴드리머 및 그의 배합물
KR102612882B1 (ko) 2017-05-05 2023-12-11 센터 포 프로브 디벨롭먼트 앤드 커머셜리제이션 이관능성 킬레이트 및 그의 용도의 약동학적 증진
CA3062538A1 (en) 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
US11373803B2 (en) 2017-08-11 2022-06-28 Applied Materials, Inc. Method of forming a magnetic core on a substrate
AU2019381793B2 (en) 2018-11-16 2025-02-27 The Research Foundation For The State University Of New York Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356190A (en) * 1974-06-12 1982-10-26 Personal Products Company Inhibiting production of undesirable products on body surfaces and environs employing aminopolycarboxylic compounds
JPS62238213A (ja) * 1986-04-04 1987-10-19 Maab:Kk 脱臭用清浄布収納パツク
JPH0825861B2 (ja) * 1989-04-24 1996-03-13 サンスター株式会社 歯磨組成物
US5236695A (en) 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
US5147632A (en) * 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
AU3324193A (en) * 1991-12-10 1993-07-19 Dow Chemical Company, The Oral compositions for inhibiting plaque and calculus formation
US5409689A (en) 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
EP0955044B1 (en) 1995-06-26 2005-11-16 Chelator LLC Method of inhibiting bacterial or fungal growth using a complexing agent
FR2737204B1 (fr) * 1995-07-26 1997-09-12 Oreal Derives de n,n'-di(aralkyl)n,n'-di(carboxylakyl)alkylene di- ou triamine et de n-(aralkyl)n'-(carboxyalkyl) n,n'-di(carboxyalkyl)alkylene di- ou triamine et leur utilisation en pharmacie et en cosmetique
FR2749845B1 (fr) * 1996-06-18 1998-08-21 Oreal Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques
US6165966A (en) * 1996-09-24 2000-12-26 The Procter & Gamble Company Liquid detergents containing proteolytic enzyme and protease inhibitors
EP1248591B1 (en) * 2000-01-18 2007-08-08 Unilever Plc Anti-microbial compositions comprising a salt of a transition metal chelator
GB0001129D0 (en) * 2000-01-18 2000-03-08 Unilever Plc Anti-microbial aerosol compositions
US6264966B1 (en) * 2000-02-22 2001-07-24 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury

Also Published As

Publication number Publication date
JP2003523394A (ja) 2003-08-05
US6387891B2 (en) 2002-05-14
WO2001062262A1 (en) 2001-08-30
US6264966B1 (en) 2001-07-24
AU2001237038A1 (en) 2001-09-03
ATE406902T1 (de) 2008-09-15
EP1261349A1 (en) 2002-12-04
CA2399299A1 (en) 2001-08-30
IL151031A (en) 2009-06-15
IL151031A0 (en) 2003-04-10
ES2239924T1 (es) 2005-10-16
EP1261349A4 (en) 2004-09-01
EP1261349B1 (en) 2008-09-03
DE01909263T1 (de) 2004-08-26
CA2399299C (en) 2009-11-17
US20010041170A1 (en) 2001-11-15
EP2011501A1 (en) 2009-01-07

Similar Documents

Publication Publication Date Title
DE60135638D1 (de) Verbindung mit chelationsaffinität und selektivitäe
CA2613509A1 (en) Carrier strip for application to oral surfaces and related methods
WO2003043517A3 (en) Dentifrice compositions
AR034300A1 (es) Metodos para mejorar la higiene dental animal
RU2012108729A (ru) Композиция для ухода за полостью рта
ATE174787T1 (de) Polymerzusammensetzung zum bleichen von zähnen und andere anwendungen davon
MX9307358A (es) Composicion para higiene bucal.
DK321787A (da) Usninsyrepraeparater
AU2007338828B2 (en) Anti-calculus dental composition and methods for using same
JP2003523394A5 (https=)
PT966256E (pt) Produto para a higiene e saude bucais
ES2648218T3 (es) Procedimientos de mantenimiento de la higiere oral en animales utilizando derivados de morfolina
BRPI0411521A (pt) composição de alimento para animais de estimação
GR950100243A (el) Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
PE103198A1 (es) Composiciones antimicrobianas para el cuidado bucal y composiciones para el tratamiento de la enfermedad periodontal y el mal olor del aliento
ATE370724T1 (de) Mundpflegemittel enthaltend einen fluor-ion- vektor und ein antioxidationsmittel
Addy Local delivery of antimicrobial agents to the oral cavity
ITMI20020421A1 (it) Colluttorio per l'igiene orale a base di clorexidina
PE102898A1 (es) Composiciones antimicrobianas para el cuidado bucal y composiciones para el tratamiento de la enfermedad periodontal y el mal olor del aliento
CA2626099A1 (en) Oral composition containing morin
CA2547654A1 (en) Use of osteopontin in dental formulations
KR100632802B1 (ko) 치주질환 치료 및 예방용 마우스피스
Antonio et al. Antiplaque and antigingivitic activity of an oral rinse containing cetylpyridinium chloride-A randomized clinical trial
MXPA02008502A (es) Preparaciones para la higiene oral, antiplaca y antibacteriana que contienen aceite de oliva.
Nguyen et al. Evaluation and Comparison of Patient Feedback on Chlorhexidine Vs Anti-Calculus Mouthrinse after 6 Months of Compliance

Legal Events

Date Code Title Description
8364 No opposition during term of opposition